References
- Ho V, Soiffer RJ. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001; 98: 3192–204
- Handgretinger R, Lang P, Schumm M, et al. Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant 1998; 21: 987–93
- Lang P, Klingebiel T, Bader P, et al. CD34+ cell transplants. Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases. Bone Marrow Transplant 2004; 33: 25–32
- Van Heeckeren WJ, Vollweiler J, Fu P, et al. Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device. Br J Haematol 2006; 132: 42–55
- Samijn JP, te Boekhorst PA, Mondria T, et al. Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis. J Neurol Neurosurg Psychiatry 2006; 77: 46–50
- Verburg RJ, Kruize AA, van den Hoogen FH, et al. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum 2001; 44: 754–60
- McNiece I, Briddell R, Stoney G, et al. Large-scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recovery. J Hematother 1997; 6: 5–11
- Schumm M, Lang P, Taylor G, et al. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother 1999; 8: 209–18
- Després D, Flohr T, Uppenkamp M, et al. CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACS device. J Hematother 2000; 9: 557–64
- Del Fante C, Perotti C, Viarengo G, et al. Immunomagnetic cell selection performed for HLA haploidentical transplants with the CliniMACS device: effect of additional platelet removal on CD34+ cell recovery. Stem Cells Dev 2005; 14: 734–9
- Watts MJ, Somervaille TC, Ings SJ, et al. Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 3001 (v2.5) clinical scale devices. Br J Haematol 2002; 118: 117–23
- Sutherland DR, Anderson L, Keeney M, et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996; 5: 213–26
- Sutherland R, Keeney M, Gratama JW. Enumeration of CD34+ hematopoietic stem and progenitor cells. In: Downey T. Current Protocols in Cytometry. Somerset: John Wiley & Sons, 2003, unit 6.4.
- Arpaci F, Cetin T, Özet A, et al. The excessive numbers of total nucleated cells does not affect the performance of the CliniMACS. J Clin Apheresis 2004; 19: 197–201
- Perseghin P, Gaipa G, Dassi M, et al. CD34+ stem cell recovery after positive selection of ‘overloaded’ immunomagnetic columns. Stem Cells Dev 2005; 14: 740–3